Histone methylases as novel drug targets: developing inhibitors of EZH2.
about
EZH2 in Bladder Cancer, a Promising Therapeutic TargetIdentification of (R)-N-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (CPI-1205), a Potent and Selective Inhibitor of Histone Methyltransferase EZH2, SAnti-inflammatory and chondroprotective effects of the S-adenosylhomocysteine hydrolase inhibitor 3-Deazaneplanocin A, in human articular chondrocytes.Inhibition of Histone Demethylases Offers a Novel and Promising Approach for the Treatment of Cancer and Other Diseases.Identification of an easy to use 3D culture model to investigate invasion and anticancer drug response in chondrosarcomas.The rise of epigenetic drug discovery.Structure of the PRC2 complex and application to drug discovery.Anti-cancer effects of curcumin on lung cancer through the inhibition of EZH2 and NOTCH1.MiR-101-3p Regulates the Viability of Lung Squamous Carcinoma Cells via Targeting EZH2.Evaluation of the impact of S-adenosylmethionine-dependent methyltransferase inhibitor, 3-deazaneplanocin A, on tissue injury and cognitive function in mice.
P2860
Q28082054-74B12A4C-7A64-488E-BD84-4953F3D89219Q33746209-C2F48B17-4CF2-4D99-A0BB-B7E36E443819Q38430720-D4E39B97-0885-4FC9-844A-9D84B8E9E989Q38433781-CED87188-C917-4EF2-AF0D-5819B152AF2DQ38696894-E4B6F01B-3E34-4252-A53D-B3D687BC0192Q38823638-A50C0E2C-EF35-4A30-9039-B05025A0333BQ39245946-D4EC36C8-49C7-450C-B89B-09190BCD118EQ41225460-7F1BAA97-C17E-4614-984E-B0D5D3C03CE9Q51267160-29D52A9B-090F-4408-A6A9-2E465D6D88C2Q54988946-79387116-7365-49A3-92B1-264B0F4529A9
P2860
Histone methylases as novel drug targets: developing inhibitors of EZH2.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Histone methylases as novel drug targets: developing inhibitors of EZH2.
@ast
Histone methylases as novel drug targets: developing inhibitors of EZH2.
@en
type
label
Histone methylases as novel drug targets: developing inhibitors of EZH2.
@ast
Histone methylases as novel drug targets: developing inhibitors of EZH2.
@en
prefLabel
Histone methylases as novel drug targets: developing inhibitors of EZH2.
@ast
Histone methylases as novel drug targets: developing inhibitors of EZH2.
@en
P2860
P50
P356
P1476
Histone methylases as novel drug targets: developing inhibitors of EZH2
@en
P2093
Céline Bazille
Eva Lhuissier
P2860
P304
P356
10.4155/FMC.14.123
P577
2014-01-01T00:00:00Z